search
Back to results

A Multicenter Study to Evaluate the ROX Anastomotic Coupler System (ACS) In Patients With Severe Hypertension

Primary Purpose

Hypertension

Status
Completed
Phase
Phase 2
Locations
Belgium
Study Type
Interventional
Intervention
ROX ANASTOMOTIC COUPLER SYSTEM (ACS)
ROX Anastomotic Coupler System (ACS)
Sponsored by
ROX Medical, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension focused on measuring High Blood Pressure, Hypertension, Resistant Hypertension

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of severe hypertension must be made on the basis of current findings, medical history, and physical examination

Exclusion Criteria:

  • Any serious medical condition that may adversely affect the patient's safety, limit the subject's ability to participate in the study, comply with follow-up requirements or impact the scientific integrity of the study.

Sites / Locations

  • Universitair Ziekenhuis Brussel

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Group A

Arm Description

ROX Anastomic Coupler System (ACS) + continuing standard antihypertensive medications

Outcomes

Primary Outcome Measures

Change in mean office SBP
Change in mean office SBP at six months as compared to Baseline

Secondary Outcome Measures

Change in mean office DBP
Change in mean office DBP at six months as compared to Baseline

Full Information

First Posted
September 5, 2012
Last Updated
January 27, 2015
Sponsor
ROX Medical, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT01682057
Brief Title
A Multicenter Study to Evaluate the ROX Anastomotic Coupler System (ACS) In Patients With Severe Hypertension
Official Title
A Prospective, Non-Randomized, Open Label, Multi-Center Study to Evaluate the ROX Anastomotic Coupler System (ACS) in Patients With Severe Hypertension
Study Type
Interventional

2. Study Status

Record Verification Date
January 2015
Overall Recruitment Status
Completed
Study Start Date
October 2011 (undefined)
Primary Completion Date
March 2013 (Actual)
Study Completion Date
March 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ROX Medical, Inc.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the safety and performance of the ROX Anastomotic Coupler System (ACS) in patients with severe hypertension.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
High Blood Pressure, Hypertension, Resistant Hypertension

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
8 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group A
Arm Type
Experimental
Arm Description
ROX Anastomic Coupler System (ACS) + continuing standard antihypertensive medications
Intervention Type
Device
Intervention Name(s)
ROX ANASTOMOTIC COUPLER SYSTEM (ACS)
Intervention Description
The ROX Anastomic Coupler (ACS) will be used to create an arteriovenous fistula in the iliac region (between the iliac artery and vein).
Intervention Type
Device
Intervention Name(s)
ROX Anastomotic Coupler System (ACS)
Primary Outcome Measure Information:
Title
Change in mean office SBP
Description
Change in mean office SBP at six months as compared to Baseline
Time Frame
Baseline, 6 months
Secondary Outcome Measure Information:
Title
Change in mean office DBP
Description
Change in mean office DBP at six months as compared to Baseline
Time Frame
Change in mean office DBP six months as compared to Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of severe hypertension must be made on the basis of current findings, medical history, and physical examination Exclusion Criteria: Any serious medical condition that may adversely affect the patient's safety, limit the subject's ability to participate in the study, comply with follow-up requirements or impact the scientific integrity of the study.
Facility Information:
Facility Name
Universitair Ziekenhuis Brussel
City
Brussels
ZIP/Postal Code
1090
Country
Belgium

12. IPD Sharing Statement

Learn more about this trial

A Multicenter Study to Evaluate the ROX Anastomotic Coupler System (ACS) In Patients With Severe Hypertension

We'll reach out to this number within 24 hrs